Pirosa MC, Zhang L, Hitz F, Novak U, et al. A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Leuk Lymphoma 2022;63:117-123.
PMID: 34407735